KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Tax ProvisionsTax Rate
Others
Ratios

BioNTech SE (BNTX) Tax Provisions (2018 - 2025)

Historic Tax Provisions for BioNTech SE (BNTX) over the last 8 years, with Q3 2025 value amounting to $62.4 million.

  • BioNTech SE's Tax Provisions rose 24427.49% to $62.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $156.3 million, marking a year-over-year increase of 16300.0%. This contributed to the annual value of -$13.3 million for FY2024, which is 9518.56% up from last year.
  • Latest data reveals that BioNTech SE reported Tax Provisions of $62.4 million as of Q3 2025, which was up 24427.49% from $18.2 million recorded in Q2 2025.
  • BioNTech SE's Tax Provisions' 5-year high stood at $1.5 billion during Q1 2022, with a 5-year trough of -$1.8 billion in Q4 2021.
  • For the 5-year period, BioNTech SE's Tax Provisions averaged around -$265.3 million, with its median value being -$43.3 million (2024).
  • Its Tax Provisions has fluctuated over the past 5 years, first crashed by 92063100345.86% in 2021, then surged by 94616.76% in 2025.
  • Quarter analysis of 5 years shows BioNTech SE's Tax Provisions stood at -$1.8 billion in 2021, then soared by 151.51% to $912.0 million in 2022, then tumbled by 124.22% to -$220.9 million in 2023, then skyrocketed by 120.17% to $44.6 million in 2024, then skyrocketed by 40.1% to $62.4 million in 2025.
  • Its Tax Provisions stands at $62.4 million for Q3 2025, versus $18.2 million for Q2 2025 and $31.1 million for Q1 2025.